TARS - Tarsus Pharmaceuticals appoints Farro as CFO CSO
2023-04-24 09:52:24 ET
- Tarsus Pharmaceuticals ( NASDAQ: TARS ) has announced the appointment of Jeff Farrow as Chief Financial Officer and Chief Strategy Officer, effective immediately.
- Mr. Farrow succeeds Leo Greenstein who served as CFO since 2020 and will be leaving Tarsus to pursue other professional interests.
- Most recently, Jeff served as CFO at Global Blood Therapeutics, where he was an integral part of the leadership team that secured regulatory approval and successfully commercialized Oxbryta for the treatment of sickle cell disease.
For further details see:
Tarsus Pharmaceuticals appoints Farro as CFO, CSO